Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Jianming Zheng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5101061108. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers

Papers 13

  1. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40644-021-00443-1↗
  2. Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy. Co-author DOI 10.3389/fimmu.2022.863346↗
  3. Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section H… Last author DOI 10.3389/fonc.2021.694933↗
  4. Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Ima… Last author DOI 10.3389/fonc.2021.740212↗
  5. Progress in Animal Models of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.7150/jca.37529↗
  6. Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001404↗
  7. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1. Last author DOI 10.1159/000495328↗
  8. Microarray Analysis of the Expression Profile of Long Non-Coding RNAs Indicates lncRNA RP11-263F15.1 as a Biomarker for Diagnosis and Prognostic Prediction of … Last author DOI 10.7150/jca.18073↗
  9. Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies. Last author DOI 10.1038/srep38936↗
  10. LncRNAs in pancreatic cancer. Last author DOI 10.18632/oncotarget.10545↗
  11. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4. Last author DOI 10.1097/mpa.0000000000000283↗
  12. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression. Co-author DOI 10.1186/1756-9966-32-86↗
  13. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival. Co-author DOI 10.1371/journal.pone.0076450↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hui Jiang · 6 shared papers, 2016–2022 · strength 0.59
  2. Yanfang Liu · 3 shared papers, 2020–2022 · strength 0.45
  3. Yun Bian · 3 shared papers, 2019–2022 · strength 0.37
  4. Na Ta · 5 shared papers, 2015–2018 · strength 0.34
  5. Xiaoyi Huang · 4 shared papers, 2016–2018 · strength 0.29
  6. Meng Guo · 2 shared papers, 2020–2021 · strength 0.29
  7. Chengwei Shao · 2 shared papers, 2021–2022 · strength 0.28
  8. Jianping Lu · 2 shared papers, 2019–2021 · strength 0.23
  9. Suizhi Gao · 2 shared papers, 2019–2022 · strength 0.22
  10. Kai Cao · 2 shared papers, 2019–2022 · strength 0.22
  11. Li Wang · 2 shared papers, 2019–2022 · strength 0.22
  12. Gang Jin · 2 shared papers, 2019–2022 · strength 0.22
  13. Kaiwen Kong · 1 shared paper, 2020 · strength 0.16
  14. Jin Wang · 1 shared paper, 2022 · strength 0.16
  15. Jianping Lu · 1 shared paper, 2022 · strength 0.14
  16. Chao Ma · 1 shared paper, 2022 · strength 0.14
  17. Shiwei Guo · 1 shared paper, 2022 · strength 0.14
  18. Guiling Ding · 1 shared paper, 2021 · strength 0.13
  19. Zailong Cai · 2 shared papers, 2013–2015 · strength 0.10
  20. Jingjing Deng · 2 shared papers, 2013–2015 · strength 0.10
  21. Kailian Zheng · 1 shared paper, 2018 · strength 0.08
  22. Ke Yang · 1 shared paper, 2015 · strength 0.05
  23. Hongyu Wu · 1 shared paper, 2013 · strength 0.03
  24. Zhao‐Shen Li · 1 shared paper, 2013 · strength 0.03
  25. Shu-De Li · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.